<DOC>
	<DOCNO>NCT02990299</DOCNO>
	<brief_summary>The purpose research study determine benefit cost include health coach , clinical pharmacist mobile health ( mHealth ) tool text message videoconferencing diabetes management support service African-Americans Latinos uncontrolled Type 2 Diabetes .</brief_summary>
	<brief_title>mHealth Diabetes Adherence Support</brief_title>
	<detailed_description>Many African-Americans Latinos diabetes achieve recommend diabetes goal place high risk complication . Team-based model care help reach goal therapy . Additionally , mobile health ( mHealth ) technology improve outcome among difficult reach . This study evaluate impact team-based , mHealth intervention design improve medication adherence , healthy eating , physical activity behavior . The investigator compare mHealth approach usual care . Clinical pharmacist health coach ( HC ) deliver propose team-based intervention . mHealth delivery include mobile phone text messaging , secure videoconferencing , HC home visit . Pharmacists focus medication reconciliation adherence . Health coach help identify psychosocial environmental challenge adherence culturally-sensitive manner . Together , assist goal-setting , problem-solving , negotiation compete priority , provide social support leverage mHealth technology . Preliminary data previous research research team support role health coach partner clinic- base pharmacist improve diabetes outcomes minority . In proposed mHealth intervention , patient- pharmacist videoconferencing eliminate need in-person visit pharmacist , impractical many low-income patient . In addition , pilot work suggest text message preferable mean communication may facilitate frequent contact patient . This randomize , control trial evaluate effectiveness mHealth diabetes adherence support intervention deliver clinical pharmacist health coach . The research team randomize 220 patient UI Health either : ( 1 ) mHealth diabetes adherence support clinical pharmacist health coach ; ( 2 ) usual care . After one year , patient complete mHealth intervention monitor additional year usual care group receive mHealth approach . Outcomes include medication adherence , hemoglobin A1c , blood pressure , LDL-cholesterol level . The specific aim include : ( 1 ) evaluate effectiveness mHealth diabetes adherence support intervention deliver clinical pharmacist health coach African-American Latino adult uncontrolled type 2 diabetes ; ( 2 ) evaluate maintenance improve diabetes behavior well clinical outcome one year complete intervention ; ( 3 ) evaluate cost cost-effectiveness mHealth diabetes adherence support compare usual care ; ( 4 ) evaluate reach , adoption , implementation mHealth diabetes adherence support base RE-AIM framework .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Selfidentified Latino/Hispanic AfricanAmerican Verbal fluency English Spanish Latest A1c â‰¥ 8.0 % ( within 3 mo ) History Type 2 Diabetes ( &gt; 1 year ) Between age 21 75 year Unlimited mobile phone/text messaging plan ability reply text message Home environment capable video conferencing wireless signal Receives primary care UI Health clinical site least one year , one visit past year Able willing provide inform consent ( agree data collection requirement , accept randomization , agree home visitation HC pharmacist involvement , participate two year ) Unable verbalize comprehension study impaired decision make Family/household member already participate study Currently receive regular pharmacist support Medication Therapy Management equivalent History , plan , gastric bypass transplant surgery History bipolar psychotic disorder Other severe comorbidities require complex , aggressive , palliative treatment , e.g. , stage 4 great renal disease , liver failure , cancer ( nonmelanoma skin cancer ) , terminal illness Investigator discretion safety concern</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Diabetes Mellitus , Type 2</keyword>
	<keyword>Medication Adherence</keyword>
	<keyword>Telemedicine</keyword>
	<keyword>Community Health Workers</keyword>
	<keyword>Pharmacists</keyword>
	<keyword>Mobile Health</keyword>
</DOC>